Pharmacobiochemistry of arylalkyltriazenes and their application in cancer chemotherapy

This publication has 81 references indexed in Scilit:

• Pharmacokinetics of dacarbazine (DTIC) and its metabolite 5-aminoimidazole-4-carboxamide (AIC) following different dose schedules
  Cancer Chemotherapy and Pharmacology, 1982
• Tumour inhibitory triazenes: Structural requirements for an active metabolite
  Biochemical Pharmacology, 1976
• Combination chemotherapy for disseminated malignant melanoma
  Cancer, 1975
• Studies on the mechanism of action of the tumour inhibitory triazenes
  Biochemical Pharmacology, 1973
• Combination Chemiotherapy with 5-(3,3 dimethyl-1-triazeno) imidazole-4-carboxamide (DTIC; NSC-45388), 1,3-bis (2-chloroethyl)-1-nitrosourea (BCNU; NSC-409962) and Vincristine (VCR; NSC - 67574) in Metastatic Malignant Melanoma
  Tumori Journal, 1973
• Therapy of malignant melanoma with an imidazole carboxamide and bis-chloroethyl nitrosourea
  Cancer, 1972
• Triple combination chemotherapy of disseminated melanoma
  Cancer, 1972
• Imidazole carboxamide therapy in advanced malignant melanoma
  Cancer, 1971
• Single crystal studies of chemotherapeutic agents. I. Structure of 1-(2-chloroethyl)-3-(5-carbamoylimidazol-4-yl)-.DELTA.2-1,2,3-triazolinium chloride
  Journal of Medicinal Chemistry, 1969
• Synthesen mit Diazobenzolimid
  European Journal of Inorganic Chemistry, 1903